Citations for
1KIR2DL4
Extensive Alternative Splicing of KIR Transcripts.
Bruijnesteijn J, van der Wiel MKH, de Groot N, Otting N, de Vos-Rouweler AJM, Lardy NM, de Groot NG, Bontrop RE.
Front Immunol 9:2846. doi: 10.3389/fimmu.2018.02846. eCollection 2018. 2018
2KIR2DL4
Possible Involvement of Human Mast Cells in the Establishment of Pregnancy via Killer Cell Ig-Like Receptor 2DL4.
Ueshima C, Kataoka TR, Hirata M, Sugimoto A, Iemura Y, Minamiguchi S, Nomura T, Haga H.
Am J Pathol 188(6):1497-1508. doi: 10.1016/j.ajpath.2018.02.012. Epub 2018 Mar 22. 2018
3HLAG, KIR2DL4
The Influence of Cytomegalovirus on Expression of HLA-G and its Ligand KIR2DL4 by Human Peripheral Blood Leucocyte Subsets.
Albayati Z, Alyami A, Alomar S, Middleton D, Bonnett L, Aleem S, Flanagan BF, Christmas SE.
Scand J Immunol 86(5):396-407. doi: 10.1111/sji.12594. Epub 2017 Sep 19. 2017
4KIR2DL4
KIR2DL4 expression rather than its single nucleotide polymorphisms correlates with pre-eclampsia.
Wang D, Tian Y, Zhao Y, Liu L, Liu X, Wu F.
Int J Clin Exp Pathol 8(11):14535-41. eCollection 2015. 2015
5KIR2DL4
The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4.
Moradi S, Berry R, Pymm P, Hitchen C, Beckham SA, Wilce MC, Walpole NG, Clements CS, Reid HH, Perugini MA, Brooks AG, Rossjohn J, Vivian JP.
J Biol Chem 290(16):10460-71. doi: 10.1074/jbc.M114.612291. Epub 2015 Mar 10. 2015
6KIR2DL4
Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling.
Rajagopalan S, Long EO.
Proc Natl Acad Sci U S A 109(50):20596-601. doi: 10.1073/pnas.1208248109. Epub 2012 Nov 26. 2012
7KIR2DL4, RNF216
Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-κB signaling.
Miah SM, Purdy AK, Rodin NB, MacFarlane AW 4th, Oshinsky J, Alvarez-Arias DA, Campbell KS.
J Immunol 186(5):2959-69. doi: 10.4049/jimmunol.1000112. Epub 2011 Jan 26. 2011
8HLA-G, KIR2DL4
HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells.
Li C, Houser BL, Nicotra ML, Strominger JL.
Proc Natl Acad Sci U S A 106(14):5767-72. Epub 2009 Mar 20. 2009
9KIR2DL4
Possible gene-gene interaction of KIR2DL4 with its cognate ligand HLA-G in modulating risk for preeclampsia.
Tan CY, Chong YS, Loganath A, Chan YH, Ravichandran J, Lee CG, Chong SS.
Reprod Sci 16(12):1135-43. Epub 2009 Aug 21.PMID: 19700612 2009
10KIR2DL2, KIR2DL4
DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors.
Liu Y, Kuick R, Hanash S, Richardson B.
Clin Immunol 130(2):213-24. Epub 2008 Oct 22.PMID: 18945643 2009
11KIR2DL4
The elucidation of KIR2DL4 gene polymorphism.
Schellekens J, Tilanus MG, Rozemuller EH.
Mol Immunol 45(7):1900-6. Epub 2007 Dec 21.PMID: 18082267 2008
12KIR2DL4
KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules.
Miah SM, Hughes TL, Campbell KS.
J Immunol 180(5):2922-32.PMID: 18292514 2008
13KIR2DL4
Cloning and sequencing alleles of the KIR2DL4 gene from genomic DNA samples.
Roberts CH, Madrigal JA, Marsh SG.
Tissue Antigens 69 Suppl 1:88-91.PMID: 17445175 2007
14KIR3DL3, KIR2DL4
Three structurally and functionally divergent kinds of promoters regulate expression of clonally distributed killer cell Ig-like receptors (KIR), of KIR2DL4, and of KIR3DL3.
Trompeter HI, G—mez-Lozano N, Santourlidis S, Eisermann B, Wernet P, Vilches C, Uhrberg M.
J Immunol 174(7):4135-43. 2005
15KIR3DL1, KIR2DL4
Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters.
Stewart CA, Van Bergen J, Trowsdale J.
J Immunol 170(12):6073-81. 2003
16KIR2DL4
KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
Faure M, Long EO.
J Immunol 168(12):6208-14. 2002
17KIR2DL4
Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR103.
Selvakumar A, Steffens U, Palanisamy N, Chaganti RS, Dupont B.
Tissue Antigens 49(6):564-73. 1997
18KIR2DL4
NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains.
Selvakumar A, et al.
Tissue Antigens 48 : 285-294. 1996
19KIR2DL2, KIR2DL3, KIR2DL4, KIR2DS1, KIR2DS2, KIR2DS3, KIR2DS4, KIR2DS5
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
Moretta A, Sivori S, Vitale M, Pende D, Morelli L, Augugliaro R, Bottino C, Moretta L.
J Exp Med 182 : 875-884. 1995